News Articles Tagged: Lipid-Lowering Therapies

Clofibrate: A Pharmaceutical Ingredient for Lipid-Lowering Therapies from China

Explore the benefits of Clofibrate (CAS 637-07-0) as a key pharmaceutical ingredient for lipid-lowering therapies, and discover why sourcing from China offers advantages.

Fenofibric Acid: The Chemical Backbone of Advanced Lipid-Lowering Therapies

Delve into the chemical profile of Fenofibric Acid (CAS 42017-89-0), its role as a PPARα agonist, its applications as a pharmaceutical intermediate, and market insights for sourcing this vital compound.

Lomitapide vs. Other Lipid-Lowering Therapies: A Comparative Overview

Compare Lomitapide with other lipid-lowering therapies, highlighting its unique mechanism as an MTP inhibitor and its specific role in treating HoFH.